Ada Braun

Ada Braun is a seasoned professional in the pharmaceutical industry, currently serving as the Regulatory Affairs Therapeutic Area Head and Executive Director of Regulatory Affairs at Pharmacyclics, an AbbVie Company, since February 2017. Prior to this role, Ada held the position of SVP Clinical Development at AROG Pharmaceuticals, Inc. from October 2015 to August 2016 and was the Chief Medical Officer at Biothera from March 2014 to July 2015. Ada has also contributed to Amgen as an Executive Medical Director in Hematology/Oncology and as a Clinical Research Medical Director from November 2006 to February 2014. Academically, Ada holds a PhD in Oncology/Pharmacology from Vanderbilt University and an MD from Paris-Sud University (Paris XI), along with additional training from UCLA Anderson School of Management.